<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01418846</url>
  </required_header>
  <id_info>
    <org_study_id>ML7401</org_study_id>
    <nct_id>NCT01418846</nct_id>
  </id_info>
  <brief_title>Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients</brief_title>
  <official_title>Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the intra-saliva penetration of voriconazole in
      different subpopulations. The goal is to develop, optimize and validate an easy, non-invasive
      and painless procedure for Therapeutic Drud Monitoring of voriconazole that can be used in
      children, ambulatory patients and in patients in whom blood drawing is difficult.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Voriconazole pharmacokinetics in saliva and plasma in different patient populations</measure>
    <time_frame>One day at steady state of voriconazole plasma levels</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">11</enrollment>
  <condition>Pneumology</condition>
  <condition>Hematology</condition>
  <condition>Internal Medicine</condition>
  <condition>Pediatrics</condition>
  <arm_group>
    <arm_group_label>adult hematology patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>pediatric patients age 5-18years</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>adult pneumology patients</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized at the pneumology ward, adult hematology ward and all hospitalized
        pediatric patients, treated with voriconazole.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients from the adult hematology ward treated with voriconazole

          -  pediatric patients treated with voriconazole, age 5-18 years

          -  patients from the pneumology ward treated with voriconazole

        Exclusion Criteria:

          -  Age under 5 years

          -  Women who are pregnant or lactating

          -  Mucositis stage 3 or 4 (WHO)

          -  Patients which received the following drugs within 14 days before study entry:
             rifampicin, rifabutin, carbamazepine, phenytoin, phenobarbital, nevirapine, efavirenz
             and barbiturates.

          -  Patients which received the following drugs within 24hours before study entry:
             quinidine, ergotamine, sirolimus, saquinavir, amprenavir, nelfinavir, ritonavir and
             sulphonylureas.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kim Vanstraelen, R.Ph.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catholic University of Leuven, Faculty of Pharmacy, division Hospital Pharmacy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ghent University Hospital - Cystic Fibrosis Clinic</name>
      <address>
        <city>Ghent</city>
        <state>East Flanders</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Brussels - Cystic Fibrosis Clinic</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2011</study_first_submitted>
  <study_first_submitted_qc>August 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2011</study_first_posted>
  <last_update_submitted>January 12, 2015</last_update_submitted>
  <last_update_submitted_qc>January 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>voriconazole</keyword>
  <keyword>saliva</keyword>
  <keyword>pharmacokinetics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Voriconazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

